STONERIDGE INC (SRI)

US86183P1021 - Common Stock

6.08  +0.11 (+1.84%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SRI. SRI was compared to 82 industry peers in the Automobile Components industry. While SRI seems to be doing ok healthwise, there are quite some concerns on its profitability. SRI does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

SRI had negative earnings in the past year.
In the past year SRI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SRI reported negative net income in multiple years.
Of the past 5 years SRI 4 years had a positive operating cash flow.

1.2 Ratios

SRI has a Return On Assets of -1.11%. This is in the lower half of the industry: SRI underperforms 79.27% of its industry peers.
Looking at the Return On Equity, with a value of -2.72%, SRI is doing worse than 78.05% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.99%, SRI is doing worse than 81.71% of the companies in the same industry.
Industry RankSector Rank
ROA -1.11%
ROE -2.72%
ROIC 1.99%
ROA(3y)-0.8%
ROA(5y)1.26%
ROE(3y)-1.88%
ROE(5y)2.49%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SRI's Operating Margin of 1.35% is on the low side compared to the rest of the industry. SRI is outperformed by 81.71% of its industry peers.
SRI's Operating Margin has declined in the last couple of years.
SRI's Gross Margin of 20.92% is on the low side compared to the rest of the industry. SRI is outperformed by 70.73% of its industry peers.
In the last couple of years the Gross Margin of SRI has declined.
Industry RankSector Rank
OM 1.35%
PM (TTM) N/A
GM 20.92%
OM growth 3YN/A
OM growth 5Y-25.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.77%
GM growth 5Y-6.92%

4

2. Health

2.1 Basic Checks

SRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SRI has been increased compared to 1 year ago.
SRI has less shares outstanding than it did 5 years ago.
The debt/assets ratio for SRI is higher compared to a year ago.

2.2 Solvency

SRI has an Altman-Z score of 2.54. This is not the best score and indicates that SRI is in the grey zone with still only limited risk for bankruptcy at the moment.
SRI has a Altman-Z score (2.54) which is in line with its industry peers.
The Debt to FCF ratio of SRI is 19.31, which is on the high side as it means it would take SRI, 19.31 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 19.31, SRI is doing worse than 75.61% of the companies in the same industry.
SRI has a Debt/Equity ratio of 0.72. This is a neutral value indicating SRI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.72, SRI is not doing good in the industry: 81.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 19.31
Altman-Z 2.54
ROIC/WACC0.23
WACC8.78%

2.3 Liquidity

SRI has a Current Ratio of 2.44. This indicates that SRI is financially healthy and has no problem in meeting its short term obligations.
SRI's Current ratio of 2.44 is amongst the best of the industry. SRI outperforms 81.71% of its industry peers.
A Quick Ratio of 1.40 indicates that SRI should not have too much problems paying its short term obligations.
The Quick ratio of SRI (1.40) is better than 81.71% of its industry peers.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 1.4

2

3. Growth

3.1 Past

SRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.33%, which is quite impressive.
SRI shows a decrease in Revenue. In the last year, the revenue decreased by -5.92%.
SRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.41% yearly.
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
Revenue 1Y (TTM)-5.92%
Revenue growth 3Y14.62%
Revenue growth 5Y2.41%
Sales Q2Q%-10.22%

3.2 Future

SRI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 61.06% yearly.
Based on estimates for the next years, SRI will show a decrease in Revenue. The Revenue will decrease by -1.16% on average per year.
EPS Next Y-102%
EPS Next 2Y61.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.64%
Revenue Next 2Y-0.84%
Revenue Next 3Y-1.16%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SRI. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 60.20, the valuation of SRI can be described as expensive.
Based on the Price/Forward Earnings ratio, SRI is valued a bit more expensive than 79.27% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.73. SRI is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 60.2

4.2 Price Multiples

SRI's Enterprise Value to EBITDA ratio is in line with the industry average.
SRI's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 16.56
EV/EBITDA 6.42

4.3 Compensation for Growth

A more expensive valuation may be justified as SRI's earnings are expected to grow with 61.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.06%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SRI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STONERIDGE INC

NYSE:SRI (1/6/2025, 3:58:05 PM)

6.08

+0.11 (+1.84%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)N/A N/A
Inst Owners102.24%
Inst Owner Change0%
Ins Owners2.55%
Ins Owner Change0.24%
Market Cap168.36M
Analysts86.67
Price Target14.28 (134.87%)
Short Float %0.97%
Short Ratio0.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)272.28%
Min EPS beat(2)-397.03%
Max EPS beat(2)941.58%
EPS beat(4)2
Avg EPS beat(4)27.23%
Min EPS beat(4)-444.55%
Max EPS beat(4)941.58%
EPS beat(8)5
Avg EPS beat(8)66.12%
EPS beat(12)7
Avg EPS beat(12)64.56%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.53%
Min Revenue beat(2)-7.81%
Max Revenue beat(2)-3.25%
Revenue beat(4)1
Avg Revenue beat(4)-1.85%
Min Revenue beat(4)-7.81%
Max Revenue beat(4)6.19%
Revenue beat(8)4
Avg Revenue beat(8)0.66%
Revenue beat(12)8
Avg Revenue beat(12)4.19%
Revenue beat(16)11
Avg Revenue beat(16)4.37%
PT rev (1m)0%
PT rev (3m)-33.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-121.05%
EPS NY rev (1m)0%
EPS NY rev (3m)-270%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.62%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 60.2
P/S 0.18
P/FCF 16.56
P/OCF 4.3
P/B 0.62
P/tB 0.88
EV/EBITDA 6.42
EPS(TTM)-0.18
EYN/A
EPS(NY)0.1
Fwd EY1.66%
FCF(TTM)0.37
FCFY6.04%
OCF(TTM)1.41
OCFY23.24%
SpS33.21
BVpS9.8
TBVpS6.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.11%
ROE -2.72%
ROCE 2.52%
ROIC 1.99%
ROICexc 2.24%
ROICexgc 2.73%
OM 1.35%
PM (TTM) N/A
GM 20.92%
FCFM 1.11%
ROA(3y)-0.8%
ROA(5y)1.26%
ROE(3y)-1.88%
ROE(5y)2.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-30.87%
ROICexc growth 3YN/A
ROICexc growth 5Y-28.67%
OM growth 3YN/A
OM growth 5Y-25.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.77%
GM growth 5Y-6.92%
F-Score6
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 19.31
Debt/EBITDA 4.1
Cap/Depr 81.56%
Cap/Sales 3.15%
Interest Coverage 0.79
Cash Conversion 81.65%
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 1.4
Altman-Z 2.54
F-Score6
WACC8.78%
ROIC/WACC0.23
Cap/Depr(3y)93.26%
Cap/Depr(5y)100.56%
Cap/Sales(3y)3.66%
Cap/Sales(5y)4.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
EPS Next Y-102%
EPS Next 2Y61.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.92%
Revenue growth 3Y14.62%
Revenue growth 5Y2.41%
Sales Q2Q%-10.22%
Revenue Next Year-4.64%
Revenue Next 2Y-0.84%
Revenue Next 3Y-1.16%
Revenue Next 5YN/A
EBIT growth 1Y-27.71%
EBIT growth 3YN/A
EBIT growth 5Y-23.8%
EBIT Next Year139.83%
EBIT Next 3Y48.45%
EBIT Next 5YN/A
FCF growth 1Y114.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y196.15%
OCF growth 3Y-44.31%
OCF growth 5Y-42.8%